78.30 USD
↗ 0.13 (0.17%)AT CLOSE (03:59 PM EST)
BridgeBio Pharma, Inc. Common Stock (BBIO) trades at $78.30 per share. There is a divergence between signals — technical indicators rate "Strong Buy" but underlying fundamentals lean "Sell". Notable factors include a concerning Altman Z-Score in the distress zone, exceptional Return on Equity (35.6%) and a bearish Death Cross on the long-term moving averages. Valuation-wise, the stock is priced at a premium — multiples like P/E and EV/EBITDA sit above sector averages.
Technical & fundamental data as of Nov 13, 2026.